CG Oncology, Inc.
CGON
$75.03
$0.320.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -224.38M | -186.75M | -161.00M | -151.48M | -128.08M |
| Total Depreciation and Amortization | 2.96M | 2.26M | 1.45M | 596.00K | 201.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.20M | 28.44M | 24.93M | 22.94M | 16.63M |
| Change in Net Operating Assets | 1.75M | -3.97M | 2.28M | 11.16M | 17.43M |
| Cash from Operations | -178.47M | -160.01M | -132.35M | -116.79M | -93.82M |
| Capital Expenditure | -876.00K | -422.00K | -134.00K | -336.00K | -238.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -21.97M | -21.97M | -21.97M | -21.97M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -342.03M | -371.51M | -223.72M | -137.11M | -142.21M |
| Cash from Investing | -364.88M | -393.90M | -245.82M | -159.41M | -142.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 548.51M | 546.44M | 153.91M | 278.22M | 226.28M |
| Repurchase of Common Stock | -194.00K | -174.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 45.00K | -131.00K | -316.00K | -277.00K | -547.00K |
| Cash from Financing | 548.36M | 546.14M | 153.59M | 277.94M | 225.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.01M | -7.77M | -224.58M | 1.73M | -10.53M |